US HB5723 | 2017-2018 | 115th Congress

Status

Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: Engrossed on June 20 2018 - 50% progression, died in committee
Action: 2018-06-20 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Expanding Oversight of Opioid Prescribing and Payment Act of 2018

Sponsors


History

DateChamberAction
2018-06-20SenateReceived in the Senate and Read twice and referred to the Committee on Finance.
2018-06-19HouseMotion to reconsider laid on the table Agreed to without objection.
2018-06-19HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
2018-06-19HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
2018-06-19HouseConsidered under suspension of the rules. (consideration: CR H5264-5265)
2018-06-19HouseMr. Roskam moved to suspend the rules and pass the bill, as amended.
2018-06-19HousePlaced on the Union Calendar, Calendar No. 592.
2018-06-19HouseCommittee on Energy and Commerce discharged.
2018-06-19HouseReported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
2018-05-22HouseReferred to the Subcommittee on Health.
2018-05-16HouseOrdered to be Reported (Amended) by Voice Vote.
2018-05-16HouseCommittee Consideration and Mark-up Session Held.
2018-05-09HouseReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2018-05-09HouseReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2018-05-09HouseIntroduced in House

Same As/Similar To

HB6 (Related) 2018-10-24 - Became Public Law No: 115-271.
HR1099 (Similar To) 2018-09-28 - Motion to reconsider laid on the table Agreed to without objection.

Subjects


US Congress State Sources


Bill Comments

feedback